• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纯化促卵泡激素治疗期间,通过监测内源性促黄体生成素释放来预测和预防卵巢过度刺激

Prediction and prevention of ovarian hyperstimulation by monitoring endogenous luteinizing hormone release during purified follicle-stimulating hormone therapy.

作者信息

Mizunuma H, Andoh K, Yamada K, Takagi T, Kamijo T, Ibuki Y

机构信息

Department of Obstetrics and Gynecology, Gunma University School of Medicine, Japan.

出版信息

Fertil Steril. 1992 Jul;58(1):46-50. doi: 10.1016/s0015-0282(16)55135-8.

DOI:10.1016/s0015-0282(16)55135-8
PMID:1624022
Abstract

OBJECTIVE

To elucidate whether early detection of premature luteinizing hormone (LH) release can be useful for prediction and prevention of ovarian hyperstimulation during purified follicle-stimulating hormone (FSH) therapy.

DESIGN

Retrospective and prospective study.

PATIENTS

Infertile women with polycystic ovarian syndrome.

MAIN OUTCOME MEASURES

Correlation between rate of endogenous LH release and incidence of excessive ovarian enlargement. In the prospective study, LH was measured by fluorometric enzyme immunoassay to obtain real-time concentration. Maximal ovarian diameter by ultrasonography.

RESULTS

The rate of excessive ovarian enlargement (greater than or equal to 60 mm) in cycles that were treated by a daily administration of purified FSH and accompanied by premature LH release was 83.3%. This rate was significantly higher than that in cycles without premature LH release (24.1%, P less than 0.001). Interruption of FSH administration or alternate day FSH administration in cycles with premature LH release reduced the rate of ovarian enlargement to 45.5% (P less than 0.05).

CONCLUSION

Early detection of premature LH release is useful for prediction of ovarian hyperstimulation. Ovarian hyperstimulation can be reduced by modulating the dose of FSH and the interval of administration in cycles with premature LH release.

摘要

目的

阐明在纯化促卵泡激素(FSH)治疗期间,早期检测促黄体生成素(LH)过早释放是否有助于预测和预防卵巢过度刺激。

设计

回顾性和前瞻性研究。

患者

多囊卵巢综合征不孕女性。

主要观察指标

内源性LH释放率与卵巢过度增大发生率之间的相关性。在前瞻性研究中,采用荧光酶免疫测定法测量LH以获得实时浓度。通过超声检查测量卵巢最大直径。

结果

每日给予纯化FSH治疗且伴有LH过早释放的周期中,卵巢过度增大(大于或等于60mm)的发生率为83.3%。该发生率显著高于无LH过早释放的周期(24.1%,P<0.001)。在LH过早释放的周期中,中断FSH给药或隔日给予FSH可将卵巢增大率降低至45.5%(P<0.05)。

结论

早期检测LH过早释放有助于预测卵巢过度刺激。通过在LH过早释放的周期中调整FSH剂量和给药间隔,可以降低卵巢过度刺激的发生。

相似文献

1
Prediction and prevention of ovarian hyperstimulation by monitoring endogenous luteinizing hormone release during purified follicle-stimulating hormone therapy.在纯化促卵泡激素治疗期间,通过监测内源性促黄体生成素释放来预测和预防卵巢过度刺激
Fertil Steril. 1992 Jul;58(1):46-50. doi: 10.1016/s0015-0282(16)55135-8.
2
The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.内源性促性腺激素释放在纯化尿促卵泡素治疗期间卵巢肿大病因学中的作用。
Fertil Steril. 1991 Jan;55(1):66-72.
3
Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.重组卵泡刺激素和重组促黄体生成素联合 GnRH 拮抗剂方案与单独使用重组卵泡刺激素方案在年龄≥35 岁患者卵巢刺激中的随机对照研究。
Hum Reprod. 2015 May;30(5):1188-95. doi: 10.1093/humrep/dev038. Epub 2015 Mar 3.
4
LH/FSH ratio as a predictor of ovarian hyperstimulation syndrome.
Hum Reprod. 1997 Apr;12(4):869-70. doi: 10.1093/humrep/12.4.869.
5
Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.多囊卵巢综合征:即使对于既往超反应患者,低剂量促卵泡生成素给药也是一种安全的刺激方案。
Hum Reprod. 1992 Sep;7(8):1085-9. doi: 10.1093/oxfordjournals.humrep.a137797.
6
The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.基础促黄体生成素与促卵泡生成素比值在多囊卵巢综合征患者辅助生殖技术治疗中的预后价值
Hum Reprod. 1995 Oct;10(10):2545-9. doi: 10.1093/oxfordjournals.humrep.a135742.
7
Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.多囊卵巢综合征患者促排卵过程中卵巢多卵泡反应的早期预测
Fertil Steril. 1997 Mar;67(3):459-62. doi: 10.1016/s0015-0282(97)80069-6.
8
An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation.在第三天促卵泡生成素水平正常的情况下,第三天促卵泡生成素与促黄体生成素的比值(FSH:LH)升高预示着对控制性卵巢过度刺激反应不良。
Fertil Steril. 1996 Mar;65(3):588-93. doi: 10.1016/s0015-0282(16)58159-x.
9
Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).使用尿促性素(Metrodin)或重组促卵泡生成素(Puregon)进行控制性卵巢过度刺激后的雌二醇和免疫反应性抑制素样分泌模式。
Hum Reprod. 1996 May;11(5):962-7. doi: 10.1093/oxfordjournals.humrep.a019332.
10
Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.多囊卵巢疾病患者采用固定方案,使用低剂量“纯”促卵泡生成素进行促排卵。
Int J Fertil Menopausal Stud. 1993 May-Jun;38(3):152-9.

引用本文的文献

1
Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.脂质代谢紊乱与卵巢过度刺激综合征:一项回顾性分析
Front Physiol. 2020 Nov 19;11:491892. doi: 10.3389/fphys.2020.491892. eCollection 2020.